Anti-beta 2 glycoprotein I antibodies in centenarians. 2004

P L Meroni, and D Mari, and D Monti, and R Coppola, and M Capri, and S Salvioli, and A Tincani, and R Gerli, and C Franceschi
Allergy, Clinical Immunology and Rheumatology Unit, Department of Internal Medicine, University of Milan, IRCCS Istituto Auxologico Italiano, Via G. Spagnoletto 3, 20149 Milan, Italy. pierluigi.meroni@unimi.it

BACKGROUND Non-organ-specific autoantibodies are present in centenarians without evidence of autoimmune diseases but conflicting or no data on anti-phospholipid and anti-phospholipid binding proteins were reported. OBJECTIVE To investigate the presence and antigen specificity of anti-phospholipid and anti-phospholipid binding proteins in centenarians. METHODS Seventy-seven centenarians, 70 adult controls, 65 unselected elderly subjects, and 38 old SENIEUR volunteers were investigated. Anti-cardiolipin, anti-human beta 2 glycoprotein I, and lupus anticoagulant were detected. Antigen specificity was assayed against plates coated with anionic, neutral and cationic phospholipids and beta 2 glycoprotein I-dependence was also evaluated. RESULTS 54.3% of the centenarians were positive for IgG and 8.6% for IgM anti-beta 2 glycoprotein I antibodies, while only 20.7% centenarians were positive for anti-cardiolipin IgG and 2.59% for IgM; none resulted positive for lupus anticoagulant. Anti-cardiolipin positive sera cross-reacted with negatively charged phospholipids and displayed decreased binding to serum-free cardiolipin-coated plates that was restored by human beta 2 glycoprotein I or fetal calf serum. CONCLUSIONS Centenarians display high reactivity against human beta 2 glycoprotein I but low binding to the bovine molecule in the anti-cardiolipin assay. In spite of the presence of antibodies comparable to those found in patients with the anti-phospholipid syndrome, no vascular events were reported suggesting the presence of unknown protective factors and/or the lack of triggering factors.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008297 Male Males
D002308 Cardiolipins Acidic phospholipids composed of two molecules of phosphatidic acid covalently linked to a molecule of glycerol. They occur primarily in mitochondrial inner membranes and in bacterial plasma membranes. They are the main antigenic components of the Wassermann-type antigen that is used in nontreponemal SYPHILIS SERODIAGNOSIS. Cardiolipin,Diphosphatidylglycerol,Diphosphatidylglycerols
D005260 Female Females
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging

Related Publications

P L Meroni, and D Mari, and D Monti, and R Coppola, and M Capri, and S Salvioli, and A Tincani, and R Gerli, and C Franceschi
January 1995, Clinical reviews in allergy & immunology,
P L Meroni, and D Mari, and D Monti, and R Coppola, and M Capri, and S Salvioli, and A Tincani, and R Gerli, and C Franceschi
December 1997, British journal of rheumatology,
P L Meroni, and D Mari, and D Monti, and R Coppola, and M Capri, and S Salvioli, and A Tincani, and R Gerli, and C Franceschi
January 1995, Clinical reviews in allergy & immunology,
P L Meroni, and D Mari, and D Monti, and R Coppola, and M Capri, and S Salvioli, and A Tincani, and R Gerli, and C Franceschi
January 1994, Annales de biologie clinique,
P L Meroni, and D Mari, and D Monti, and R Coppola, and M Capri, and S Salvioli, and A Tincani, and R Gerli, and C Franceschi
June 2005, Autoimmunity reviews,
P L Meroni, and D Mari, and D Monti, and R Coppola, and M Capri, and S Salvioli, and A Tincani, and R Gerli, and C Franceschi
February 2005, Autoimmunity,
P L Meroni, and D Mari, and D Monti, and R Coppola, and M Capri, and S Salvioli, and A Tincani, and R Gerli, and C Franceschi
June 2005, Autoimmunity reviews,
P L Meroni, and D Mari, and D Monti, and R Coppola, and M Capri, and S Salvioli, and A Tincani, and R Gerli, and C Franceschi
January 1993, Dermatology (Basel, Switzerland),
P L Meroni, and D Mari, and D Monti, and R Coppola, and M Capri, and S Salvioli, and A Tincani, and R Gerli, and C Franceschi
September 2000, Journal of autoimmunity,
P L Meroni, and D Mari, and D Monti, and R Coppola, and M Capri, and S Salvioli, and A Tincani, and R Gerli, and C Franceschi
September 1996, Annales de medecine interne,
Copied contents to your clipboard!